Myriad Genetics
Latest Myriad Genetics News
-
Myriad Supreme Court Ruling Leading to New Gene Tests
unanimous decision, the court threw out some patents for Myriad Genetics , effectively ending the firm's two-decade monopoly ruling will open opportunities to develop new tests. Myriad Genetics makes the only tests for two breast cancer genes
-
PM Note: Syria Crosses Red Line, Obama in No Hurry, Bill Clinton's Rwanda Amnesia
BRCA Gene Patent: The Supreme Court ruled today that isolated human genes cannot be patented, a partial defeat for Myriad Genetics , a company that had been awarded patents on the so-called BRCA1 and BRCA2 genes in the 1990s. But the court
-
Supreme Court Strikes Down BRCA Gene Patent
patented, a partial defeat for Myriad Genetics , a company that had been awarded are eligible for patents. " Myriad did not create anything," Justice which had challenged the patents. " Myriad did not invent the BRCA genes and
-
Will Angelina Jolie Boost Biotech Stocks?Always a Lifesaver Shares of Myriad Genetics Inc ., a company that works in human farmer in a seed patent dispute. Myriad Genetics developed an expensive test called Court heard oral arguments from Myriad Genetics ' attorneys who said the company
-
Can You Patent Human Genes?decisions about her ongoing treatment. Myriad Genetics was awarded patents in the 1990s cancer. Because of the patent, Myriad is the only place to go for testing stunned to learn that the patents give Myriad the right to prevent others from
-
Health Highlights: May 13, 2009
ago by the U.S. Patent and Trademark Office to grant Myriad Genetics , based in Salt Lake City, exclusive rights to two genes second opinion, the Times reported. Companies like Myriad argue that the patent system promotes innovation by giving
News
-
Split Realities for Sisters With Breast Cancer Genestill decided to hold off." Helpful Genetic Test or Nerve Rattler The availability of the blood test, marketed by Myriad Genetics , and a recent advertising campaign to promote it, have raised concerns about whether the ads create undue anxiety
-
'De-Tangling' Alzheimer's Drug Shows Promise
which was targeted at reducing the sticky amyloid plaques in the brain. In June, the drug's manufacturer, Myriad Genetics , announced that the agent had failed to effectively treat Alzheimer's disease. The company is no longer developing
-
Hopes Dashed for Alzheimer's Drugyear alone. On June 30, Myriad Genetics Inc . announced that its drug development of this compound," Myriad 's CEO Peter Meldrum said in a statement. Flurizan Flurizan on brain function, Myriad researchers narrowed the patient
-
Health Highlights: July 1, 2008
disappointing results in a late-stage clinical trial and development of the drug will be halted, Salt Lake City-based Myriad Genetics announced Monday. Compared to a placebo, the drug didn't improve thinking ability by a statistically significant
-
Health Highlights: June 30, 2008
disappointing results in a late-stage clinical trial and development of the drug will be halted, Salt Lake City-based Myriad Genetics announced Monday. Compared to a placebo, the drug didn't improve thinking ability by a statistically significant
-
Health Highlights: May 22, 2007
brain associated with Alzheimer's, the AP reported. Current drugs only help control symptoms of the disease. Myriad Genetics Inc . has already started Phase III trials of its drug Flurizan, and Medivation Inc. expects to begin Phase III trials
-
Cancer Docs Debate Gene Test Ad Campaignis marketed by the company Myriad Genetic Laboratories Inc. and costs more than National Cancer Institute. Myriad contends that these tests may the mutation." However, Myriad Genetics argues that extensive genetic
